Monday, February 7, 2022

February 07, 2022 at 08:20PM GRASTEK

Product approval information for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro testing for pollen-specific IgE antibodies for Timothy grass or cross-reactive grass pollens. GRASTEK is approved for use in persons 5 through 65 years of age

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/24gPHOm

No comments:

Post a Comment